Can-Fite BioPharma (CANF) Reports 2024 Financial Results and Clinical Update

Go back to Can-Fite BioPharma (CANF) Reports 2024 Financial Results and Clinical Update
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.40 --0 (-0%)
Previous Close $3.40    52 Week High $3.89 
Open $3.40    52 Week Low $1.85 
Day High $3.40    P/E N/A 
Day Low $3.40    EPS $0.00 
Volume 1,197